By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



11095 Flintkote Avenue
Suite D
San Diego  California  92121  U.S.A.
Phone: Fax:



Company News
Ignyta (RXDX) Announces Initiation Of STARTRK-1 Global Phase I/II Clinical Trial Of RXDX-101 7/21/2014 11:21:37 AM
Ignyta (RXDX) To Be Added To Russell Microcap® Index 6/25/2014 11:44:30 AM
Ignyta Announces Interim Data From RXDX-101 Phase I Clinical Trial 6/2/2014 9:30:49 AM
Ignyta Reports Granting Of Inducement Awards 5/30/2014 8:45:52 AM
Ignyta Announces First Quarter 2014 Company Highlights And Financial Results 5/12/2014 7:06:19 AM
Ignyta Announces RXDX-101 Phase I Data Abstract Accepted For Oral Presentation At The 2014 American Society of Clinical Oncology Annual Meeting 5/8/2014 7:41:59 AM
Ignyta To Report 2014 First Quarter Company Highlights And Financial Results And Host Conference Call On May 12, 2014 5/5/2014 7:30:50 AM
Ignyta Reports Granting Of Inducement Awards 4/2/2014 9:50:19 AM
Ignyta Announces Underwriters’ Full Exercise Of Option to Purchase Additional Shares in Public Offering of Common Stock 3/18/2014 9:13:46 AM
Ignyta Announces Pricing Of Public Offering Of Common Stock 3/14/2014 8:51:23 AM